These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16187973)

  • 1. No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.
    Nonen S; Okamoto H; Akino M; Matsui Y; Fujio Y; Yoshiyama M; Takemoto Y; Yoshikawa J; Azuma J; Kitabatake A
    Br J Clin Pharmacol; 2005 Oct; 60(4):414-7. PubMed ID: 16187973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study.
    Metra M; Zani C; Covolo L; Nodari S; Pezzali N; Gelatti U; Donato F; Nardi G; Dei Cas L
    Eur J Heart Fail; 2006 Mar; 8(2):131-5. PubMed ID: 16188498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.
    Du Preez J; Matolweni LO; Greenberg J; Mntla P; Adeyemo AA; Mayosi BM
    Cardiovasc J Afr; 2008; 19(1):15-6. PubMed ID: 18320080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
    Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
    J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
    Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
    Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure.
    Small KM; Wagoner LE; Levin AM; Kardia SL; Liggett SB
    N Engl J Med; 2002 Oct; 347(15):1135-42. PubMed ID: 12374873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry.
    Woodiwiss AJ; Badenhorst D; Sliwa K; Brooksbank R; Essop R; Sareli P; Norton GR
    Cardiovasc J Afr; 2008; 19(4):188-93. PubMed ID: 18776959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
    Fragoso JM; Rodríguez-Pérez JM; González J; Cruz D; Pérez-Méndez O; de Jesus García J; de la Peña A; Arce M; Reyes PA; Vargas-Alarcón G
    Exp Mol Pathol; 2006 Jun; 80(3):279-82. PubMed ID: 16487965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy.
    Reddy S; Fung A; Manlhiot C; Tierney ES; Chung WK; Blume E; Kaufman BD; Goldmuntz E; Colan S; Mital S
    Pediatr Res; 2015 Feb; 77(2):363-9. PubMed ID: 25406899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinatorial pharmacogenetic interactions of bucindolol and β1, α2C adrenergic receptor polymorphisms.
    O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Walsh R; Nelson P; Medway A; Davis G; Robertson AD; Port JD; Carr J; Murphy GA; Lazzeroni LC; Abraham WT; Liggett SB; Bristow MR
    PLoS One; 2012; 7(10):e44324. PubMed ID: 23071495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.
    Pereira SB; Velloso MW; Chermont S; Quintão MM; Nunes Abdhala R; Giro C; Oliveira E Alves T; Camacho V; De Fátima Maia Contarato L; Pena FM; Balieiro HM; Garcia ML; Da Nóbrega AC; Ribeiro GS; Mesquita ET
    Mol Med Rep; 2013 Jan; 7(1):259-65. PubMed ID: 23064657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume.
    Canham RM; Das SR; Leonard D; Abdullah SM; Mehta SK; Chung AK; Li JL; Victor RG; Auchus RJ; Drazner MH
    J Am Coll Cardiol; 2007 Jan; 49(2):274-6. PubMed ID: 17222742
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy.
    Iwai C; Akita H; Shiga N; Takai E; Miyamoto Y; Shimizu M; Kawai H; Takarada A; Kajiya T; Yokoyama M
    Circ J; 2002 Aug; 66(8):723-8. PubMed ID: 12197595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy.
    Amar J; Brunel J; Cardot Bauters C; Jacques V; Delmas C; Odou MF; Savagner F
    Endocr Relat Cancer; 2022 Apr; 29(5):267-272. PubMed ID: 35258481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2C-adrenoceptor polymorphism is associated with improved event-free survival in patients with dilated cardiomyopathy.
    Regitz-Zagrosek V; Hocher B; Bettmann M; Brede M; Hadamek K; Gerstner C; Lehmkuhl HB; Hetzer R; Hein L
    Eur Heart J; 2006 Feb; 27(4):454-9. PubMed ID: 16299019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenergic receptor polymorphisms and prevention of ventricular arrhythmias with bucindolol in patients with chronic heart failure.
    Aleong RG; Sauer WH; Robertson AD; Liggett SB; Bristow MR
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):137-43. PubMed ID: 23275278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy.
    Ogimoto A; Okayama H; Nagai T; Suzuki J; Inoue K; Nishimura K; Shigematsu Y; Tabara Y; Miki T; Higaki J
    Circ J; 2012; 76(8):2003-8. PubMed ID: 22664639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.